Clinical Trial Update: LeMaitre LifeSpan® ePTFE Vascular Graft Retrospective Registry

View source ↗

Summary

A completed retrospective registry update evaluating the LifeSpan ePTFE Vascular Graft for use in diseased or occluded blood vessels and arteriovenous shunting …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• End-stage Renal Disease
• Peripheral Artery Disease

Drugs mentioned

• LifeSpan ePTFE Vascular Graft (expanded polytetrafluoroethylene vascular graft)

Snippet

Sponsor: LeMaitre Vascular | Conditions: Diseased or Occluded Blood Vessels, Arteriovenous Shunting for Blood Access | Status: COMPLETED